A Trial of SHR-1701 in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Pancreatic Cancer
Clinical trial NCT04624217 · COMPLETED
Trial details
- NCT number
- NCT04624217
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-24
- Primary completion
- 2021-09-16
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.